Background: Contamination of bone marrow and peripheral blood stem cells with tumor cells is a problem that may be encountered when autologous hematopoietic stem cell transplantation is conducted concurrently with high-dose chemotherapy. Methods: Using monoclonal antibodies to a variety of tumors, the detection of tumor cells in the bone marrow of breast cancer patients was studied by immunohistochemistry. Results: KL-1 and CAM5.2 were strongly reactive with breast cancer cells, but not with normal bonemarrow cells. Thereactivity of thetumorcells with EMA wasnotstrong, andOF-3 and11508 yielded only slightly positive reactions. These latter antibodies also exhibited some reactivity to normal bone marrow cells. When tumor cells were admixed with normal cells, the sensitivity of CAM5.2 and EMA permitted the detection of one cell in 10 4 , but with KL-1 , the detection of one in 10 5 cells was possible. When immunohistochemical staining was used in testing 40 patients with advanced or recurrent breast cancer, positive reactions were obtained in four of 27 patients (14.8%) with KL-1, four of 26 (15.4%) with CAM5.2, and nineof 37 (23.7%) with KL-1 + CAM5.2, figures similar to those reported by others who studied stage IV patients. Conclusions: Immunohistochemical staining with KL-1 and CAM5.2 is therefore considered to be a useful technique for detecting contamination by tumor cells.
INTRODUCTION
The combination of autologous hematopoietic stem cell transplantation and high-dose chemotherapy is a promising therapeutic technique in advanced cases of breast cancer. In our institution, we have used autologous bone marrow and peripheral blood stem cell transplantation with high-dose chemotherapy since 1980 and 1991, respectively, both for advanced cases of recurrent breast cancer and postoperative multiple lymph node metastases (1) . Contamination of the autologous hematopoietic stem cells with breast cancer cells has been a problem in these procedures. Moreover, the presence of contaminant breast cancer cells in the bone marrow has been reported to serve as a predictive factor in postoperative cases (2) . The detection of contaminant Received January 5, 1998; accepted May 8, 1998 For reprints and all correspondence: Yutaka Tokuda, Department of Surgery, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. E-mail: tokuda@is.icc.u-tokai.ac.jp Abbreviations: MoAbs, monoclonal antibodies; FBS, fetal bovine serum; EDTA, ethylenediaminetetraacetic acid; PFA, paraformaldehyde; PBS, phosphate-buffered saline; NRS, normal rabbit serum; BSA, bovine rabbit albumin; CK-19, keratin-19; RT-PCR, reverse transcriptase-polymerase chain reaction breast cancer cells has been the subject of many studies, but conventional histochemical tests have proven unsatisfactory for this purpose. There have also been many reports on immunohistochemical staining methods using monoclonal antibodies (MoAbs), but none addressed the problem from the viewpoint of basic medicine. We therefore undertook basic research on many questions concerning the reactivity of MoAbs and sought to identify which antibodies were effective in detecting contamination by breast cancer cells.
MATERIALS AND METHODS

BREAST CANCER CELL LINES
The breast cancer cell lines SK-BR-3, MDA-MB-453, ZR75-l and MCF7 were purchased from the American Type Culture Collection (Rockville, MD, USA). The cell lines were cultured in either RPM! 1640 or Dulbecco's Modified Eagle Medium (Hazelton Research Products, Kansas City, MO, USA), containing 10% fetal bovine serum (FBS) (Gibco Laboratories, Grand Island, NY, USA). All the cell lines tested negative for mycoplasma contamination. Before use, the cell lines were processed in 0.25% trypsin and 0.15% ethylenediaminetetraacetic acid (EDTA) in an incubator at 37°C, then carefully scraped free from the wall of the incubating dishes. The cells were then washed in RPMI 1640 containing 10% PBS, and a viable cell count was made.
MONOCLONAL ANTIBODIES KL-l (Immunotech, Marseille Cedex, France) (3), CAM5.2 (Becton-Dickinson, Mountain View, CA, USA) (4), EMA (EMA-E29) (DAKO, Glostrup, Denmark) (5), 115D8 (TorayFuji-Bionics, Tokyo, Japan) (6) and DF-3 (Japan Tanner, Tokyo, Japan) (7) were used. KL-l is a MoAb to keratin obtained from the keratinous layer of normal human skin, and recognizes keratins 1, 2, 3, 4, 10 and 11. CAM5.2 is a MoAb to keratin obtained from colon cancer cell line HT29, and recognizes keratins 8, 18 and 19. EMA is a MoAb against the epithelial cell membrane, and the antigens that it recognizes belong to the human milk-fat globule heterogeneous group of heavily glycosylated proteins. 115D8 is a MoAb against the highly purified human milk-fat globule membrane. Finally, DF-3 is a MoAb to the cell membrane of metastatic breast cancer cells and reacts with 290 kDa glycoproteins.
BONE MARROW CELLS
Normal bone marrow cells were harvested from the posterior iliac bone of donors for allogenic bone marrow transplantation. Other bone marrow cells were collected from the posterior iliac bone of 40 patients with advanced or recurrent breast cancer. Isolation was by the method of Gilmore et al. (8) , using a Cobe 2991 Blood Cell Processor (Cobe Laboratories, Lakewood, CO, USA). The bone marrow cells (l x 10 7/ml) were centrifuged for 15 min at 800 r.p.m., fixed for 5 min in 4% paraformaldehyde (PFA) at room temperature, then again centrifuged at 800 r.p.m. for 15 min in a cytospin process that yielded 1.5 x 10 6 cells per slide. This was followed by additional fixation in 4% PFA for 40 min. The slides were then washed for 5 min with each of the following: 5% sucrose, 10% sucrose, 0.01 M phosphate-buffered saline (PBS) and 5% normal rabbit serum (NRS).
IMMUNOHISTOCHEMICAL STAINING METHOD
The breast cancer cell lines (1 x 10 6 ) were subjected to the cytospin process, then prepared as were the bone marrow cells and affixed. The MoAbs KL-I, CAM5.2, EMA, 115D8 and DF-3, 1 ug ofprotein/ml each, were added to the various normal and experimental cell slide preparations and reacted for 30 min at 4°C, following which they were washed three times with 0.5% bovine serum albumin (BSA/PBS). The slides were pre-treated with levamisole (Sigma, St Louis, MO, USA) to inhibit the activation of endogenous alkaline phosphatase. The reactions of the cells with the antibodies were determined with alkaline phosphatase-conjugated rabbit anti-mouse IgG (DAKO, Glostrup, Denmark). The reactive cells stained a strong violet color, and were easily distinguished from non-stained cells. The diagnostic criteria were based only on reactivity, not on any morphology. 
RESULTS
REACTIVITY OF BREAST CANCER CELL LINES WITH THE
MoABS (TABLE 1) With the above immunohistochemical staining technique, most of the SK-BR-3 cells gave a strong positive staining reaction with MoAbs KL-l and CAM5.2 (97 and 95.3%, respectively), while with EMA, DF-3 and 115D8, fewer cells stained (23.7,29.8 and 49%, respectively), and the reactions were not as strong (Fig. 1) . In addition, when the positive cell ratio was defined as the number of cells with a greater intensity than the controls and expressed as a proportion of the total, flow cytometry yielded the following ..
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• CAMS.2. 94.4 ± 4.8: and EMA. 62.1 ± 39.4 (means ± SD). The overall ratio with EMA was low. but this appears to be because the values for MDA-MB-453 and MCF-7 were unusually low ( Table 2) . DETERMINEDBYIMMUNOHISTOCHEMISTRY (TABLE 3) Normal bone marrow cells were reactive with EMA. DF-3 and 11 5D8 (Fig. 2 ), but not with KL-l and CAM5.2. Wealsocollecteddata on the detection of contaminanttumorcells in the bone marrowof patients withadvancedor metastaticcancer by an immunohistochemical method using KL-I, CAM5.2 and EMA. The results are presented in Table 5 and Fig. 3 (9) . The sensitivity of flow cytometry seems to vary with the investigator, with the highest level of sensitivity reported thus far being one in ]04. However, with immunohistochemi stry, a sensitivity of one in 10 5 has been reached. Leslie et al. ( 10) considered that a detection sensitivity of one in I if was possible in flow cytometry if the mean intensity was compared with the control. Molino et al. (9) reported that whereas the maximum sensitivity obtainable with flow cytometry was one in .. In our institution, we compared two variations of the immunohistochemical staining method for tumor cell detection within the bone marrow of advanced recurrent breast cancer patients of a type generally treated with massive-dose chemotherapy. One variation tested both KL-l and CAM5.2, and the other tested EMA, which has been frequently studied in the USA and Europe. The detection of contaminant tumor cells in bone marrow is When the breast cancer cell line SK-BR-3 was used in investigating the reactivity of tumor cells with these MoAbs by examining the ratio of positively stained cells and the degree of staining, it was found that EMA gave the lowest positive ratio, DF-3 and 115D8 yielded higher ratios, and KL-I and CAM5.2 provided the highest positive ratios. As to the strength or weakness of staining, KL-I and CAM5.2 gave very good results. When KL-I and CAM5.2 were compared with EMA by flow cytometry, it was seen that EMA had a ratio of positive staining that was much lower than those of the preceding two. Moreover, when a cocktail of KL-l and CAM5.2 was used, the ratio increased, though only to a small extent.
REACTIVITY OF NORMAL BONE MARROW CELLS WITH MoABS
(c)
Next, the reactivity of these MoAbs with normal bone marrow cells was examined. DF-3, 115D8 and EMA were reactive with these cells, whereas no such reaction was obtained with KL-l and CAMS . 11) also pointed out that the reactivity of DF-3 was similar to that of EMA, but that CAM5.2 showed no reactivity with normal bone marrow cells.
As the above indicates, KL-l and CAM5.2 are highly reactive with tumor cells, but not with normal bone marrow cells. They are, therefore, suitable as reagents for the detection of contaminant tumor cells.
Study of the sensitivity of KL-l, CAM5.2 and EMA in detecting contaminant tumor cells showed a ratio of one in 10 4 for CAM5.2 and EMA, while with KL-l it was 1 in 105. The sensitivity of the method using KL-I is on a par with the highest levels of sensitivity previously reported for the detection of tumor cells with immunohistochemical staining. Mathieu et al. (13) made experimental comparisons between KL-l, AEI-AE3, CAM5.2, EMA and HMFG-2, and reported that KL-l was the most sensitive. The studies described above clearly indicate that for the detection of tumor cells as contaminants in bone marrow, KL-I possesses the highest specificity and the greatest accuracy. However, the action ofKL-1 is related to keratins 1,2,3,4,10 and II, whereas that of CAM5.2 is to keratins 8, 18 and 19. It was considered that more effective epithelial cell detection would result from combining antibodies to as many types of keratin as possible.
It was reported recently that keratin 19 (CK-19) is not present in either normal lymph nodes or normal bone marrow cells, and that lymph node metastases can be detected with a high degree of sensitivity (one cell in 10 6 ) by means of a reverse transcriptasepolymerase chain reaction (RT-PCR) using CK-19 (14) . In the study of Seiden et al. (15) , however, when they employed the RT-PCR using CK-19 to detect tumor cells in normal human peripheral blood, no positives were seen after 50 cycles, but after 70 cycles eight of 14 cases (57%) were positive. This technique can hardly be said to be a practical method of detection. In addition, although the RT-PCR can offer a qualitative diagnosis, quantitatively it is far from satisfactory, and so the usefulness of immunohistochemical staining as a method of detection is greater.
mainly used as a predictive factor (16), but there are few reports that focus specifically on advanced recurrent cancer patients, and none that make direct comparisons of anti-keratin antibodies with EMA. However, Mansi et al. (17) , using EMA, successfully detected contaminant cells in the bone marrow of 13 of 20 cases (65%) of recurrent breast cancer. Also, Ross et al. (18) reported 28 positives (70%) among 40 cases of stage IV carcinoma with the use of MoAbs to breast or glandular epithelia. In contrast, Singletary et al. (19) , using three MoAbs to keratin (AE1, AE3 and MAK -6), found positive reactions in only 38% of 71 stage IV cases. The results of our study are similar, showing a 23.7% rate of positives when both KL-1 and CAM5.2 were used, as opposed to a rate of 52.9% with the use of EMA alone. The MoAb against keratin gave a lower ratio of positives than EMA, but this was thought to be due to the number of false positives generated by the use of EMA for immunohistochemical staining.
